AI tool

Protocol planner

Pick an outcome. The planner looks up candidate compounds, copies their documented dosing, and lays out a cycle you can send straight to the calculator, to N1 Aminos, or to StackTracker.

  • ✓ Grounded in 125 profiles
  • ✓ Doses copied, never invented
  • ✓ Cited sources
  • ✓ Live stock check
  1. 1Goal—
  2. 2Experience—
  3. 3Constraints—
  4. 4Protocol

Compounds N1 Aminos stocks are listed first, so every plan can be sourced and tracked immediately.

Educational output assembled from published protocols. Not individual advice.

Example output · your plan appears here

Starting-point protocol

8-week tendon recovery (example output)

Protocols for tendon injury commonly centre on BPC-157, which has tendon-fibroblast migration data, and TB-500, studied for angiogenesis and collagen organisation. Both list 8–12 week cycles and both are stocked by N1 Aminos.

Compound A

BPC-157

Local repair signalling, gut protection

N1 stocked
Dose
250–500 mcg
Frequency
Once or twice daily
Timing
Consistent schedule, rotate sites
Cycle
8 weeks
Vial
5 mg in 2 mL BAC water

Cautions: Mostly animal data; mild injection-site reactions reported.

Compound B

TB-500

Systemic actin regulation, cell migration

N1 stocked
Dose
500 mcg → 750 mcg
Frequency
Once daily
Timing
Any time, consistent
Cycle
8 weeks
Vial
10 mg in 2 mL BAC water

Cautions: Limited human data; avoid with active malignancy per common guidance.

Sample day / week

  1. MorningBPC-157 250 mcg subcutaneous near the injury
  2. EveningTB-500 500 mcg subcutaneous (abdomen)
  3. WeeklyReview pain and range-of-motion notes in StackTracker

Watch for

  • Injection-site redness or itching
  • Unexpected fatigue or dizziness
  • No change after 4 weeks — reassess with a clinician

First order at N1 Aminos

15% off your first N1 Aminos order with code DOSING15

Educational summary assembled from published protocols. Not medical advice.

Educational use only. The protocols shown summarise published research and community practice for informational purposes. They are not medical advice, not a prescription, and not a recommendation to use any compound. Research peptides are generally not approved for human use. Consult a licensed clinician. Full disclaimer.
Ask the advisor